Glaxosmi.-Pharma Stock/Share Prices, Buy and Sell Glaxosmi.-Pharma BSE Stocks

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Large Cap

Invest

15 Feb 2019 | 03:59 PM

1,372.30

-21.30 (-1.53%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

12.41%

Return (1Y)

Beaten S&P BSE Healthcare by 18.8%
More Volatile

1.77%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 0.65%
Consistent Performer

7/12

Months

beaten S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

1,812

1,020

News & Announcements

Glaxosmithkline Pharmaceuticals standalone net profit rises 25.96% in the December 2018 quarter
12 days ago

Glaxosmithkline Pharmaceuticals standalone net profit rises 25.96% in the December 2018 quarter

04 - Feb - 2019 12:00 AM | 12 days ago

Net profit of Glaxosmithkline Pharmaceuticals rose 25.96% to Rs 112.97 crore in the quarter ended December 2018 as against Rs 89.69 crore during the previous quarter ended December 2017. Sales rose 17.25% to Rs 825.35 crore in the quarter ended December 2018 as against Rs 703.91 crore during the previous quarter ended December 2017.
Particulars Quarter Ended
Dec. 2018 Dec. 2017 % Var.
Sales 825.35 703.91 17
OPM % 16.64 20.15 -
PBDT 153.69 153.76 0
PBT 141.65 140.38 1
NP 112.97 89.69 26
Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals to hold board meeting
50 days ago

GlaxoSmithKline Pharmaceuticals to hold board meeting

28 - Dec - 2018 12:00 AM | 50 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 4 February 2019 Un-Audited Financial Results for the quarter and nine months ended 31st December, 2018
Powered by Capital Market - Live News
Glaxosmithkline Pharmaceuticals standalone net profit declines 22.67% in the September 2018 quarter
117 days ago

Glaxosmithkline Pharmaceuticals standalone net profit declines 22.67% in the September 2018 quarter

22 - Oct - 2018 12:00 AM | 117 days ago

Net profit of Glaxosmithkline Pharmaceuticals declined 22.67% to Rs 100.77 crore in the quarter ended September 2018 as against Rs 130.32 crore during the previous quarter ended September 2017. Sales declined 2.39% to Rs 816.31 crore in the quarter ended September 2018 as against Rs 836.26 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 816.31 836.26 -2
OPM % 20.23 22.97 -
PBDT 179.76 201.70 -11
PBT 168.25 193.97 -13
NP 100.77 130.32 -23
Powered by Capital Market - Live News
GlaxoSmithKline Pharmaceuticals announces board meeting date
140 days ago

GlaxoSmithKline Pharmaceuticals announces board meeting date

29 - Sep - 2018 12:00 AM | 140 days ago

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 October 2018.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

MF shareholding in Glaxosmithkline Pharma Ltd has increased by 3.67% since past 3 Months
FII shareholding in Glaxosmithkline Pharma Ltd has decreased by -12.11% since past 1 Year
MF shareholding in Glaxosmithkline Pharma Ltd has increased by 29.95% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Dec. 2018	Dec. 2017	% Var.
Sales	825.35	703.91	17
OPM %	16.64	20.15	-
PBDT	153.69	153.76	0
PBT	141.65	140.38	1
NP	112.97	89.69	26

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	816.31	836.26	-2
OPM %	20.23	22.97	-
PBDT	179.76	201.70	-11
PBT	168.25	193.97	-13
NP	100.77	130.32	-23

General Notifications

My Notifications

Research Notifications

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE Pharmaceuticals, Large Cap

1,372.30 -21.30 (-1.53%)

News & Announcements

Price vs Volume

Stock Trivia

Glaxosmithkline Pharmaceuticals Ltd NSE / BSE
Pharmaceuticals, Large Cap

1,372.30

-21.30 (-1.53%)